Fig. 1From: Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trialStandard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figure. BP blood pressure, ECG electrocardiogram, 6MWT 6-min walk test, QoL quality of life, mRSS modified Rodnan Skin ScoreBack to article page